SNFGE SNFGE
 
Thématique :
- Cancer colorectal (CCR)
Originalité :
Intermédiaire
Solidité :
Intermédiaire
Doit faire évoluer notre pratique :
Dans certains cas
 
 
Nom du veilleur :
Professeur Sylvain MANFREDI
Coup de coeur :
 
 
Journal of the National Cancer Institute (JNCI)
  2016/08  
 
  J Natl Cancer Inst (2016) 108 (12): djw171  
  doi: 10.1093/jnci/djw171  
 
  Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer  
 
  Milou H. Martens, Monique Maas, Luc A. Heijnen, Doenja M.J. Lambregts, Jeroen W. A. Leijtens, Laurents P. S. Stassen, Stephanie O. Breukink, Christiaan Hoff, Eric J. Belgers, Jarno Melenhorst, Rob Jansen, Jeroen Buijsen, Ton G. M. Hoofwijk, Regina G. H. Beets-Tan, Geerard L. Beets  
  https://academic.oup.com/jnci/article-abstract/doi/10.1093/jnci/djw171/2706932/Long-term-Outcome-of-an-Organ-Preservation-Program  
 
 

Background: The aim of this study was to establish the oncological and functional results of organ preservation with a watch-and-wait approach (W&W) and selective transanal endoscopic microsurgery (TEM) in patients with a clinical complete or near-complete response (cCR) after neoadjuvant chemoradiation for rectal cancer.

Methods: Between 2004 and 2014, organ preservation was offered if response assessment with digital rectal examination, endoscopy, and MRI showed (near) cCR. Watch-and-wait was offered for cCR, and two options were offered for near cCR: TEM or reassessment after three months. Follow-up included endoscopy and MRIs every three months during the first year, and every six months thereafter. Long-term outcome was assessed with Kaplan-Meier curves. Functional outcome was assessed with colostomy-free survival and Vaizey incontinence score (0 = perfect continence, 24 = totally incontinent).

Results: One hundred patients were included, with median follow-up of 41.1 months. Sixty-one had cCR at initial response assessment. Thirty-nine had near cCR, of whom 24 developed cCR at the second assessment and 15 patients underwent TEM (9 ypT0, 1 ypT1, 5 ypT2). Fifteen patients developed a local regrowth (12 luminal, 3 nodal), all salvageable and within 25 months. Five patients developed metastases, and five patients died. Three-year overall survival was 96.6% (95% confidence interval [CI] = 89.9% to 98.9%), distant metastasis–free survival was 96.8% (95% CI = 90.4% to 99.0%), local regrowth–free survival was 84.6% (95% CI = 75.8% to 90.5%), and disease-free survival was 80.6% (95% CI = 70.9% to 87.4%). Colostomy-free survival was 94.8% (95% CI = 88.0% to 97.8%), with a good continence after watch-and-wait (Vaizey = 3.4, SD = 3.9) and moderate after TEM (Vaizey = 9.7, SD = 5.1).

Conclusions: Organ preservation appears oncologically safe for selected rectal cancer patients with a cCR or near cCR after neoadjuvant chemoradiation when applying strict selection criteria and frequent follow-up, including endoscopy and MRI. The low colostomy rate and the good long-term functional outcome warrant discussing this option with the patient as an alternative to major surgery.

 

 
Question posée
 
Peut-on se passer de la chirurgie après radiochimiothérapie de cancer du rectum?
 
Question posée
 
Une stratégie de surveillance armée peut être proposée après réponse complète ou presque complète à une radiochimiothérapie.
 
Commentaires

Etude de cohorte de patients très sélectionnés. 

 
www.snfge.org